These Pot Stocks Won’t Stay Cheap for Long

Most of the tiny penny stocks operating in the newly formed marijuana markets are complete garbage. That’s the truth of it…

But there are a few that have a legitimate chance of becoming Blue Chip Marijuana Firms.

And that’s certainly the case for this $0.16 marijuana player.

Why?

Because it was recently revealed that they are expected to deliver “the best quarter on record” to shareholders.

All three segments of operations — construction, wholesale and retail — are being reported as profitable and self-sustaining.

Not only that, but they could be getting ready to deliver some REALLY BIG NEWS

Once the mainstream media begins covering this story… it could send share prices screaming higher.

Click here to find out how you can legally stake a claim in the best-of-the-best that this industry has to offer.

Don’t Stop Here

More To Explore

Market Brief: AI Risks and Fed Minutes Incoming

Market Snapshot Market Pulse: U.S. stocks edged sideways, buoyed by fresh AI chatter that kept tech afloat while industrial sectors shrugged off supply-chain jitters. Bond

AARD: 56% Drop Sparks Urgent Investor Scrutiny!

Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder

Gene-Editing Goldrush Meets AI and ETF Plays

Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down